Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-045221
Filing Date
2025-05-06
Accepted
2025-05-06 21:48:12
Documents
1
Period of Report
2025-05-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2514241-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2514241-2_4seq1.xml 4 14396
  Complete submission text file 0001104659-25-045221.txt   16848
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Issuer) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 601 CALIFORNIA ST SUITE 600 SAN FRANCISCO CA 94108
Business Address 601 CALIFORNIA ST SUITE 600 SAN FRANCISCO CA 94108 4157876009
Foresite Labs, LLC (Reporting) CIK: 0002027905 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-42143 | Film No.: 25919054

Mailing Address 601 CALIFORNIA ST SUITE 600 SAN FRANCISCO CA 94108
Business Address 601 CALIFORNIA ST SUITE 600 SAN FRANCISCO CA 94108 4157876009
Foresite Labs Affiliates 2021, LLC (Reporting) CIK: 0002028005 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-42143 | Film No.: 25919053